The Scorecard: 2 Month Update: VSAT Sell — Incorrect so far

Revisiting our Sell call on VSAT: entry $69.54, latest $74.18, +6.7%.

This is a Scorecard review, revisiting a past LF0 research call against what actually happened.

Ticker: VSAT Rating: Sell Published: 2026-07-11 Checkpoint: 2026-09-11 Entry price: $69.54 Latest price: $74.18 as of 2026-09-10 Stock return since entry: +6.7% Signal return: -6.7% Verdict: Incorrect so far

This is the 2-month checkpoint for this call. LF0 publishes monthly Scorecard updates through month 6, using the closest available daily close on or before the checkpoint date.

Read the original LF0 analysis

What I Said

I rated VSAT a Sell because I thought the stock was already pricing in a recovery that the operating data had not fully earned. My focus was on the gap between a still-imperfect revenue picture and a very demanding valuation, especially the 182.4x forward P/E and 3.3x EV/revenue, which I felt left too much room for disappointment. I also said I wanted to see more proof that revenue could clear $3.5B annually, operating margin could turn positive, and FCF margin could improve before I would get more constructive.

Peer Comparison

CompanyReturn Since Entry
VSAT (this call)+6.7%
CIEN-21.5%
ERIC-12.0%
GSAT+3.3%
IRDM-2.7%
VIAV-5.3%

Why It’s Working (Or Not)

So far, that call has not worked: if I had shorted VSAT at my entry price, I would be down 6.7% over the review window, so the bearish signal has lost money. The stock has moved higher while the peer group has been mostly weaker to mixed, which means VSAT has not followed the broad downtrend I was implicitly expecting from a fragile recovery story. More importantly, the specific valuation concern I highlighted has not been enough on its own to force the stock lower, and I have not yet seen the operating deterioration I warned about. At this point, the original thesis has not been validated by price action, even though the underlying business still needs to prove it can sustain the recovery I described.

What Could Still Prove Me Wrong

If revenue continues to hold above the $1.1B quarterly level and the company keeps improving EBITDA, net income, and FCF margin toward the high single digits, that would further weaken my bearish case. I would also be wrong if net debt/EBITDA stays below 4.0x while the market continues to reward the stock despite the still-rich valuation. The clearest thing that could still prove me wrong is a sustained operating inflection that makes the 182.4x forward P/E and 3.3x EV/revenue look less demanding because earnings and cash flow are finally catching up.

The July 2026 Cohort

Other directional calls published the same month:

TickerRatingEntryLatestStock ReturnSignal ReturnVerdict
NLSTSell$2.44$4.65+90.6%-90.6%Incorrect so far
BMNRSell$17.74$24.20+36.4%-36.4%Incorrect so far
SMRStrong Sell$8.81$10.21+15.9%-23.8%Incorrect so far
RDWSell$8.99$10.87+20.9%-20.9%Incorrect so far
QUBTSell$7.43$7.82+5.2%-5.2%Incorrect so far
RCATSell$7.83$8.08+3.2%-3.2%Incorrect so far
FTNTSell$156.25$158.85+1.7%-1.7%Incorrect so far
MARASell$11.67$11.43-2.1%+2.1%Correct so far
AMBASell$72.90$67.87-6.9%+6.9%Correct so far
HUTSell$98.33$90.60-7.9%+7.9%Correct so far
TPLSell$408.26$366.10-10.3%+10.3%Correct so far
TTWOSell$247.62$216.96-12.4%+12.4%Correct so far
ONTOSell$319.32$268.92-15.8%+15.8%Correct so far
AMKRSell$60.60$49.53-18.3%+18.3%Correct so far
UANBuy$110.58$135.83+22.8%+22.8%Correct so far
MYRGSell$391.51$286.84-26.7%+26.7%Correct so far
CIFRSell$21.85$15.94-27.0%+27.0%Correct so far
FLNCSell$14.42$9.69-32.8%+32.8%Correct so far
MTZSell$380.63$232.20-39.0%+39.0%Correct so far

Live LF0 scorecard: The Scorecard | Research Performance dashboard

Past performance does not guarantee future results. Nothing here is investment advice or a recommendation to buy or sell securities. Returns use LF0’s daily-close scorecard methodology.

Research disclaimer

This material is provided for research and educational purposes only. It is not investment advice, a recommendation, or an offer to buy or sell any security or strategy.

New stock analysis in your inbox.

Independent equity research on under-the-radar companies from lf0 — free, when new work publishes.




No spam. Unsubscribe anytime.

Prefer Substack? Follow lf0 Research on Substack

Leave a Comment

Your email address will not be published. Required fields are marked *